Purpose: The study examines the determinants of the quality of life (QoL) among outpatients with schizophrenia in Jordan.
BACKGROUND
Schizophrenia is a heterogeneous illness that includes psychotic features, cognitive deficits and daily performance interruption. 1 It is one of the most serious forms of mental illness and can be chronic, recurrent, disabling and debilitating among people being treated in psychiatric clinics in both developing and developed countries. 2 Schizophrenia is linked with significant changes in thought processes and behaviour (e.g. bizarre, purposeless). It is characterised by interruption in the form and content of thinking processes, emotional status, perception (e.g. hallucinations, delusions and loss of associations), language and sense of self. Usually, recurrent relapse in schizophrenia is associated with exacerbation of psychotic symptoms and deterioration in function. 1 The management of schizophrenia has shifted from hospitals towards community care. Unfortunately, the public often perceive people with mental illness as irresponsible, aggressive and dangerous. 3, 4 Moreover, people with mental illness are marginalised and discriminated against because of social stigma and stereotyping in the community, which may have an adverse impact on their quality of life (QoL). 5, 6 The healthcare system in Jordan consists of three main sectors: the Ministry of Health, the military and private systems. Each has its own funding, strategy and health insurance schemes. The Ministry of Health provides healthcare to the majority of the Jordanian population. 7, 8 Mental health care is delivered to Jordanians diagnosed with mental illness throughout four mental health hospitals and 64 outpatient clinics.
Arab culture puts more emphasis on the interdependent values and beliefs. 9 This makes Arab people attitudes towards people with mental illness vary greatly from those in western countries. Some people view schizophrenia as character weakness and laziness or punishment for not respecting ancestors, [10] [11] [12] whereas other attributes mental illness to sudden fright, possession of evil spirits, use of magic, head accidents, bad genes, emotional trauma, punishment from God or due to evil eye. 13, 14 Such beliefs about the causes of mental illness may induce the stigma from different perspectives: that mental illness is 31 a punishment for one's sins is the result of a person's weak faith 6, 15 which likely contribute to the stigma attached to mental illness in Arab cultures. 5 Stigma perceiving is associated with interfering to seek treatment from mental health service, engage in rehabilitation interventions and medication adherence. 16, 17 In addition, in Arab culture, the distinction between physical and psychological health is not widely common as has historically been prevalent in Western Cultures. Arab-Muslim literature reveals that Arab Muslims do not distinguish emotional or psychological distress from physical illness and the majority of populations tend to somatise their illness in which mental ill patient expresses an emotional disorder in the presentation of physical symptoms. 13, 18, 19 Furthermore, limited professional support impacts negatively on QoL. Taking into consideration, there is a need to identify significant predictor for people diagnosed with schizophrenia QoL in order to address these factors properly. [20] [21] [22] In developing countries, mental health patients and their families may be neglected or viewed disparagingly by society. 15 As a result, QoL is an important outcome in mental health research. 23 In recent years, QoL studies have provided an overview of the impact of mental healthcare services on health status among people with mental illness, and schizophrenia in particular. 23 QoL provides essential information that can be used for planning and evaluating clinical interventions. 24, 25 Furthermore, QoL measures indicate the level of health status improvement rather than a complete cure. 25 Although there is no consensus on a definition of QoL, it is 'an individual's perceptions of their position in life in the context of the culture and value systems where they live and in relation to their goals, expectations, standards and concerns' . 26 The findings of previous studies in Western countries show that people with schizophrenia reported significantly poorer QoL than the general population. 27, 28 In this sense, determinants of QoL among people diagnosed with mental illness have been extensively studied, including socio-demographic characteristics (i.e. gender, education level, household income, marital status), 25, 29 clinical variables (e.g. duration of illness, severity of psychiatric symptoms, number of re-hospitalisations) 30, 31 and psychosocial characteristics (social support, self-esteem, stigma). 32, 33 However, inconsistency in study findings might be explained by the using of non-specific instruments to assess QoL among people with schizophrenia, and limited number of studies have used a specific QoL tool designed for people with schizophrenia.
A meta-analysis that included 17 studies found that general psychopathology contributed to the quality of life (QoL) among people with schizophrenia more than positive and negative symptoms. 34, 35 While neurocognitive (process) is largely unrelated to subjective QoL, social cognitive contributes to subjective QoL, 36 with patients with a relatively unimpaired theory of mind reported lower subjective QoL. 34 Schizophrenia impacts several aspects of life, causing physical, psychological, and social problems related to the illness itself or to the side effects of medication. 37 QoL entails several essential dimensions, such as personal well-being, functional abilities, social interaction, psychological and economic status as well as physical health. 38 There is a paucity of psychiatric QoL studies, which used specific QoL tools designed for people with schizophrenia, either at the international level or in Jordan. In addition, schizophrenia and schizoaffective disorders are the most prevalent forms of mental illness. Broadly speaking, people diagnosed with mental illness are widely stigmatised, isolated and poorly integrated in society. 39, 40 With these concerns in mind, the QoL scales used (WHO-QOL, Chinese version of QoL, and modular system for QoL) are not specific to people with schizophrenia, being more concerned with general health. Therefore, the current study was designed to utilise a scale devised specifically to assess the QoL of people with schizophrenia. Richieri et al. 41 devised a specific tool to assess the QoL of people with schizophrenia and reported a low correlation between the former and generic QoL scales (i.e. GHQ, SF-36), which suggests that the two instruments do not measure the same elements. In addition, the generic QoL scales were developed from the point of view of experts or physicians, which may be entirely different from the views of people with schizophrenia. Likewise, Richieri et al. 5 reported that the QoL dimension for people with schizophrenia is different from that of other chronic illnesses due to the very nature of the illness. Information on QoL and its correlates will assist in developing evidence-based intervention that can improve satisfaction with multiple aspects of life among people with schizophrenia. Moreover, the scope of the previous studies focused on outpatients with schizophrenia.
Individuals with schizophrenia are not generally subject to only one stressor or demand (e.g. unemployment); thus, they are more likely to face multiple challenges (e.g. poor quality of relationship with their family caregivers). 25 Taken together, they could lead to poor QoL. So, the effective use of adaptive coping mechanism might help them to combat these negative consequences. Furthermore, weight gain and obesity are associated with negative health consequences and are prevalent in patient with schizophrenia. Previous studies have shown that increase body mass index is linked with poor QoL in general population and patient with schizophrenia. 24 Jordan is a developing country with a lower middle income level and a population of 11 million in 2015 (Department of Statistics 2016). 43 The country has a traditional extended family system, and family social support is the norm. Clarifying the relationship between QOL, social support and severity of psychiatric symptoms in Jordanian patients with schizophrenia represents an important step both in elucidating factors affecting QOL for individuals with schizophrenia and in understanding the utility of the concept of QOL for guiding future treatment. 44 Identifying predictors of QOL will also help in developing new programmes that aim to improve the QOL of people with schizophrenia. Previous studies showed that people with schizophrenia had poor knowledge about their illness. 42, 45 Moreover, the healthcare system in Jordan focuses on a biomedical model of treatment for such patients. 
MATERIALS AND METHODS

Study design and sampling
A cross-sectional, correlational research design was used to recruit participants. Each person with schizophrenia presented in the clinic, on a random basis, was invited to take part in the study. This process ceased when the target number was achieved (consecutive sampling).
Inclusion criteria were
-Living in the community with clinical stability for at least 3 months before recruitment. Clinically stable was defined as an increase in the dose of an antipsychotic drug of not more than 50% over the previous 3 months' dosage. 46 -All participants should be able to read and write English or Arabic and be willing and able to consent.
Exclusion criteria were
-Patients were excluded if they had a learning disability, or known organic mental disorder.
-Had current substance abuse, current inpatient treatment or the presence of visual, language or communication difficulties (n = 9).
Setting
The study was conducted at three mental health outpatients' clinics operated by the Ministry of Health. These clinics were chosen because they serve the majority of psychiatric patients, and were easily accessed by the researcher.
Recruitment
Jordanians with schizophrenia or schizoaffective disorder typically visit outpatient clinics monthly. A poster was displayed in these clinics advertising the study and requesting volunteers. Interested participants received further information directly from a researcher. The study recruited patients being treated in these clinics when they attended for appointments, regardless of the duration of their illness.
A study information package was given to each participant alongside a verbal explanation about the project. Sufficient time was afforded to each participant to read the information. Participants were asked to return a signed consent form to the nursing department in the clinic.
The researcher administered a study inclusion checklist to assess participants' eligibility. Then, research assistants interviewed each participant to assess their understanding of what they were consenting to, then she used instruments to assess interested outcome of measures. 
Body mass index (BMI)
The participants' body weight and height were measured using standardised equipment and procedures.
Knowledge level of schizophrenia
The knowledge about schizophrenia questionnaire (KASQ) is a selfrated questionnaire. It has 25 multiple-choice items intended to measure various aspects of schizophrenia, including basic knowledge about schizophrenia and its management, aetiology, prevalence, prognosis, treatment and anti-psychotic medication effects and side effects.
KASQ is scored from 0 to 25 with a higher score indicating greater knowledge. Cronbach's alpha was 0.88. The reason for choosing knowledge was to test whether high versus limited knowledge impacts QoL, and its correlation with the severity of psychiatric symptoms.
Severity of psychiatric symptoms
The positive and negative syndrome scale (PANSS) questionnaire was anxiety and depression. The decision to use these items in the study employed several outcome measures that might burden participants and some studies followed the same pattern. 48 
Drug-induced extrapyramidal symptoms
The drug-induced extrapyramidal symptoms scale (DIEPSS) was employed to evaluate and exclude the effect of symptoms that might affect the scoring of psychiatric severity symptoms. This scale has nine items scored from 0 to 4. 49 Cronbach's alpha was 0.86. 33
Coping strategies
A self-administered stress coping questionnaire measured coping behaviour in reaction to stressors. This scale has 114 items rated from 1 to 5. 50 It classifies coping mechanisms into three positive mechanisms and one negative. Positive coping 1 (devaluation) includes belittling, playing down or guilt defence in stressful situations. Positive coping 2 (distraction) includes diversion, relaxation and compensation.
Positive coping 3 (stress control) involves control over situations with positive self-instruction. Negative coping covers social withdrawal, resignation and self-pity. The internal consistency ranged from 0.84 to 0.94.
Quality of life
Schizophrenia quality of life (S-QoL) has 18 items measuring eight dimensions: psychological well-being (PsPhW), self-esteem, family relationship, relationship with friends, resilience, physical well-being, autonomy and sentimental life, each scoring from 1 to 5. The higher the score, the better the QoL. 51 Cronbach's alpha was 0.79-0.92. 51 Cronbach's alpha coefficient for the Arabic-translated version was 0.88, and CVI was 0.86%. 45 
Data analysis
Data were analysed using the Statistical Package for Social Sciences adjusted level of significance set at baseline for all statistical tests was thus determined at the 1% level (p < 0.01). [52] [53] [54] We conducted cluster analysis to the reduced number of levels when the variables had more than two levels. 55, 56 All the variables were entered into regression model and investigated the correlation of each studied variable with QoL subdomain.
RESULTS
We recruited 157 people with schizophrenia according to DSM-V in the period between August 2015 and February 2016. Initially, 254 participants were invited to take part in the study. However, 97 refused to cooperate or follow the study directions due to time commitment, family issues or occupation requirements; nine were excluded as they had limited comprehension ability (poor concentration or developmental disability) and six participants did not respond to the research team's contact (they refused to talk with the research team). The sample size was calculated to detect correlation between variables with a medium effect size at 0.80 power, level of significance of 0.05. 57 The participants' characteristics are summarised in Table 1 ; the majority were female, single and unemployed, with an average age of 35.6. More than two-thirds of the participants reported recurrent admission to the psychiatric hospital before the study, and a similar proportion had attained secondary level of education or higher.
BIVARIATE ANALYSIS FINDINGS
Correlation between QoL and socio-demographic characteristics
The analysis showed a significant negative correlation between QoL scores and age, as well as with male participants and a high BMI value (p˂0.05); there was also a significant negative correlation between QoL scores and illness duration (p ˂ 0.05). Furthermore, a positive significant relationship was detected between QoL and marital status. The result of correlation between QoL and being employed (r = 0.37), having less previous hospitalisation (r = -0.46) and receiving a typical antipsychotic medication (r = 0.38) were positively significantly correlated with QoL (Table 2) . However, no significant relationship was found between QoL and years of education (Table 3 ).
TA B L E 2 Characteristics of the clinical variables of the study
Correlation between QoL and clinical variables 4.3 Knowledge level of schizophrenia
The correlation between each sub-scale score of the QoL and the knowledge score was examined. The knowledge level was significantly positively correlated with QoL scores (p ˂ 0.05).
Severity of psychiatric symptoms
Surprisingly, analysis of the results revealed no significant relationship between the dimensions of QoL and the positive syndrome of schizophrenia. However, a significant correlation was obtained between QoL and negative syndrome. Another significant correlation was found between QoL and depression and anxiety.
Drug-induced extrapyramidal symptoms
The relationship between each sub-scale score on the QoL and the DIEPSS score was significantly correlated (r = -0.53, p ˂ 0.05). DIEPSS represents a general assessment of extrapyramidal symptoms. The results suggest that extrapyramidal symptoms affect QoL negatively.
Therefore, psychiatrists should strive to minimise the side effects of antipsychotic medication. A similar finding indicated that drug-induced extrapyramidal symptoms had negative impact on QoL. 58 In addition, Davis, Chen, and Glick 59 stated that patients who received typical antipsychotic medication experienced more side effects than from other typical medication.
Coping strategies
The type of coping mechanism employed has a direct relationship with the QoL score. The result demonstrated that negative coping strategies were negatively correlated with QoL sub-scales scores (r = -0.36, 
Stepwise regression analysis
The results of stepwise regression analysis on the QoL scale subdomains are summarised in 
DISCUSSION
To the best of our knowledge, this is the first study designed to examine the QoL determinants among people with schizophrenia using specific QoL instruments at an international level and in Arab-speaking countries. The current study's QoL scores were higher than those reported elsewhere for schizophrenia patients (56 vs. 47) . 24, 60 This result may be explained by the fact that participants in the current study were recruited from the outpatient clinic and were more stabilised than those being treated in a psychiatric hospital. The findings of the current study are crucial as the previous studies used the generic QoL scales based on experts' or physicians' points of view (world health organization quality of life (WHOQOL), modular system for QoL scale, subjective QoL scale), which may be entirely different from the people diagnosed with schizophrenia views. Likewise, Richieri et al. 41 reported that the QoL dimension for people with schizophrenia is different from that of other chronic illnesses due to the very nature of the illness.
The majority of the current study sample was female, as recruitment of male patients with schizophrenia is challenging and showed a higher attrition rate. In addition, the research assistants in this study were female nurses, which might contribute to recruiting female participants. Studies investigating the effect of antipsychotic medication on people with schizophrenia showed that the first generation of this medication was associated with a greater negative impact on male patients than females. 61 This might explain why the majority of the study sample was female. The present study was conducted in outpatient clinics, as the majority of people with schizophrenia have received treatment here since the start of the de-institution movement. 62 The findings of the current study indicated that the strongest predictors of QoL were negative symptoms of schizophrenia, depressive symptoms, anxiety, coping strategies and presence of extrapyramidal symptoms, given that some variables had significantly stronger associations on some measures than others. Thus, people with schizophrenia who had adequate knowledge about their condition may have a good relationship and believe their actions largely determined events and supported them with appropriate resources to overcome demands and conflict. As a result, they might have changed a hopeless view of life into a more meaningful one. This result is consistent with that of a previous report, which found that family caregivers of people with schizophrenia who had higher scores for a sense of coherence also showed a higher QoL score. 63 The lack of knowledge appeared to be confused with self-guilt, shame at the illness and a sense of helplessness and hopelessness. Alternatively, this may have reduced the self-efficacy and self-esteem of participants. This conclusion is in line with those of Lysaker, Buck, Hammoud, Taylor, and Roe 64 and Sibitz et al., 17 who argued that poor awareness of schizophrenia was associated with internalisation, stigma and stereotyping of people with schizophrenia, which led to depression. Likewise, Pickett et al. 65 and Alegría et al. 66 found poor knowledge of mental illness was linked with low self-efficacy and empowerment levels, which contributed to experiencing negative psychological effects of self and social stigma as well In recent years, more attention has been paid to the QoL of people with schizophrenia. It has been suggested that psychiatric symptoms have a greater influence on their QoL than cognitive deficit. 24 The result of our study revealed that the positive symptoms of schizophrenia had a significant correlation with all sub-domains of QoL. This outcome is contrary to that of Fujimaki et al., 24 who found positive symptoms of schizophrenia did not correlate with QoL scores. This discrepancy could partially be attributed to the fact that the majority of our study participants were at an acute stage of illness 60 and they might experience recurrent episodes of hospitalisation before being stabilised; the Fujimaki study participants had been in the chronic stage of the illness. Moreover, depression was another significant predictor of QoL. This supports the view that depression influences the patient's ability to retrieve information that could have an impact on aspects of the QoL. 68 The average age of the present study's participants was around 35 years, and individuals seek to implement their life plan at this age. However, when they perceive themselves unable 37 to achieve their goals and the acute stage of their illness requires recurrent hospitalisation, this might cause them to feel inferior to other people and erode their personality.
TA B L E 4 Stepwise regression of the predictors of quality of life
Independent variable
Regarding the association between socio-demographic characteris- The apparent overlap between the type of antipsychotic medication and QoL scores is comparable to other studies. 70, 71 Typical forms of antipsychotic medication yield more serious and undesirable side effects. This is reflected in the current study in the DIEPSS scores. It could be partially explained by the fact that patients lack interpersonal communication which adversely affects their ability to establish and sustain social relationships. In addition, public stigma and misconceptions attached to these side effects might reduce self-esteem and selfconfidence in patients. 72 The strength of the current study is the large number of patients recruited, and their random selection. However, this study has drawbacks. First, it recruited clinically stable patients with schizophrenia from the main outpatient clinics in Amman, so this finding may not be applicable to other parts of Jordan and to patients with different characteristics. Second, the percentage of female subjects was overrepresented in the sample. Thus, the results need to be interpreted with caution. Third, the nature of the study design cannot examine the causality relationship between QoL and clinical variables. Finally, this study did not assess cognitive-related function and its impact on QoL.
The current study participants were recruited from the outpatient setting who being supported by family members. So, further studies are needed to identify QoL determinant among hospitalised patients.
Moreover, the current study determined QoL for people diagnosed with schizophrenia, but other form of mental illness require further studies.
IMPLICATIONS FOR NURSING PRACTICE
The findings of this study have important clinical implications. They emphasise the necessity of understanding and treating not only the core symptoms of schizophrenia, but also the primary factors influencing changes in QoL over time. In order to adjust the clinician's goals to the patients' subjective needs, psychosocial intervention and rehabilitation programs should be directed to promote feelings of self-efficacy (empowerment), self-esteem, social support, and utilisation of adjusting and/or coping strategies as well as to support patients and their carers during the process of social adaptation in the early phase of the disease. The results of the present study highlighted that Knowldgehe level of schizophrenia significantly predicted the patient QoL.
So, effective treatment of patient diagnosed with schizophrenia must improve their understanding of the illness nature, dealing with psychiatric symptom and managing adverse effect of antipsychotic medication. To provide holistic care to patients, nurses need to not only focus on the reduction of psychiatric symptoms, but also facilitate patients' psychosocial functioning to integrate into the community.
Efforts should also emphasise engaging patients and families in the task of developing coping strategies to counteract the negative influences of stigma and enhance psychosocial functioning (e.g. greater health status and positive mutuality) to adapt to daily life stressors and demands.
CONCLUSION
The relationship between clinical variables and QoL was examined in outpatients, using specialised outcome measures. The results indicated that schizophrenia is a very demanding illness that interferes with patients' QoL. The findings identified the deleterious impact of poor knowledge about schizophrenia, typical forms of antipsychotic medication, extrapyramidal symptoms, psychiatric symptoms, duration of the illness and recurrent hospitalisation on QoL. Regarding further work, more qualitative studies are needed to explore the subjective QoL and its determinants.
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